Faizan Farooque

Faizan Farooque

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

NIO Stock Will Break Out on the Back of New Models This Year

Investors are pouring capital in Nio stock for the long-term growth story and not just the numbers. Temporary blips are a reason to buy more.

5 Autonomous Vehicles Stocks to Buy as Nvidia-Jaguar Deal Revs Up

Self-driving cars could be the next big thing on the roads and investors are pouring into autonomous vehicles stocks.

Why Block’s New Focus Will Make It A Strong Investment

Some investors questioned the business change from Block. However, the potential of SQ stock makes this firm a good investment opportunity.

Lucid Group Stock Looks Like It’s a Solid Buy Before Earnings 

LCID stock is a promising long-term EV stock that started deliveries of its first electric vehicle in late October.

Novavax Is a Buy on Recent Developments and Cheap Valuation

NVAX stock is one of the major players in the vaccine market, which is one that is expected to grow substantially over the next few years.